Cargando…
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
Despite the numerous risk factors for atherosclerotic cardiovascular diseases (ASCVD), cumulative evidence shows that electronegative low-density lipoprotein (L5 LDL) cholesterol is a promising biomarker. Its toxicity may contribute to atherothrombotic events. Notably, plasma L5 LDL levels positivel...
Autores principales: | Chu, Chih-Sheng, Law, Shi Hui, Lenzen, David, Tan, Yong-Hong, Weng, Shih-Feng, Ito, Etsuro, Wu, Jung-Chou, Chen, Chu-Huang, Chan, Hua-Chen, Ke, Liang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460408/ https://www.ncbi.nlm.nih.gov/pubmed/32751498 http://dx.doi.org/10.3390/biomedicines8080254 |
Ejemplares similares
-
Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
por: Ke, Liang-Yin, et al.
Publicado: (2020) -
An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease
por: Chan, Hua-Chen, et al.
Publicado: (2020) -
Electronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved
por: Chen, Chao-Hung, et al.
Publicado: (2016) -
Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor
por: Hsu, Jing-Fang, et al.
Publicado: (2014) -
Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice
por: Lin, Ying-Shao, et al.
Publicado: (2021)